📊 CSDX Key Takeaways
Investment Thesis
CS Diagnostics exhibits severe operational dysfunction with revenue of only $94.2K, negative operating cash flow of -$528K, and implausible balance sheet metrics (499.4M in assets with 1.6K liabilities) suggesting data integrity issues. The company demonstrates unprofitable cash generation despite reported net margins of 34.1%, indicating the operating profitability is illusory and the business model is fundamentally broken.
CSDX Strengths
- Strong reported net profit margin of 34.1%
- Zero debt and strong stated stockholders equity position
- Positive reported operating income of $32.1K
CSDX Risks
- Severe negative free cash flow of -$528K contradicts profitability claims, indicating cash burn despite reported profits
- Extremely limited revenue base of $94.2K indicates minimal business operations or severe business decline
- Implausible balance sheet with $499.4M assets against $1.6K liabilities and $13 cash suggests data quality issues or accounting abnormalities
- Zero insider activity in last 90 days indicates lack of management confidence or engagement
- Negative FCF margin of -0.6% demonstrates inability to generate positive cash despite operations
Key Metrics to Watch
- Operating cash flow trend and reconciliation with reported profitability
- Actual revenue growth and composition of asset base
- Insider transaction activity indicating management confidence
CSDX Financial Metrics
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
CSDX Profitability Ratios
CSDX vs Default Sector
How CS DIAGNOSTICS CORP. compares to Default sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
CSDX Balance Sheet & Liquidity
CSDX Growth Metrics (YoY)
CSDX Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $8.0K | $4.9K | $0.00 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
CSDX Capital Allocation
CSDX SEC Filings
Access official SEC EDGAR filings for CS DIAGNOSTICS CORP. (CIK: 0001106861)
📋 Recent SEC Filings
❓ Frequently Asked Questions about CSDX
What is the AI rating for CSDX?
CS DIAGNOSTICS CORP. (CSDX) has an AI rating of STRONG SELL with 92% confidence, based on fundamental analysis of SEC EDGAR filings.
What are CSDX's key strengths?
Strong reported net profit margin of 34.1%. Zero debt and strong stated stockholders equity position.
What are the risks of investing in CSDX?
Severe negative free cash flow of -$528K contradicts profitability claims, indicating cash burn despite reported profits. Extremely limited revenue base of $94.2K indicates minimal business operations or severe business decline.
What is CSDX's revenue and growth?
CS DIAGNOSTICS CORP. reported revenue of $94.2K.
Does CSDX pay dividends?
CS DIAGNOSTICS CORP. does not currently pay dividends.
Where can I find CSDX SEC filings?
Official SEC filings for CS DIAGNOSTICS CORP. (CIK: 0001106861) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is CSDX's EPS?
CS DIAGNOSTICS CORP. has a diluted EPS of $0.00.
How is the AI analysis conducted?
Our AI (Claude) analyzes publicly available SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports to evaluate financial health, profitability ratios, balance sheet strength, and growth metrics.